We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.
- Authors
Bloomfield, D J; Krahn, M D; Neogi, T; Panzarella, T; Smith, T J; Warde, P; Willan, A R; Ernst, S; Moore, M J; Neville, A; Tannock, I F
- Abstract
To evaluate the economic consequences of the use of chemotherapy in patients with symptomatic hormone-resistant prostate cancer (HRPC) in the context of a previously published Canadian open-label, phase III, randomized trial with palliative end points.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Vol 16, Issue 6, p2272
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1998.16.6.2272